Terms: = Breast cancer AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C AND Treatment
35 results:
1. Transformable Neuropeptide Prodrug with Tumor Microenvironment Responsiveness for Tumor Growth and Metastasis Inhibition of Triple-Negative breast cancer.
Cao Y; Ge X; Zhu X; Han Y; Wang P; Akakuru OU; Wu A; Li J
Adv Sci (Weinh); 2023 Jul; 10(21):e2300545. PubMed ID: 37147783
[TBL] [Abstract] [Full Text] [Related]
2. Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study.
Kawaguchi H; Yamamoto Y; Saji S; Masuda N; Nakayama T; Aogi K; Anan K; Ohtani S; Sato N; Takano T; Tokunaga E; Nakamura S; Hasegawa Y; Hattori M; Fujisawa T; Morita S; Yamaguchi M; Yamashita T; Yotsumoto D; Toi M; Ohno S
Jpn J Clin Oncol; 2023 Mar; 53(3):203-211. PubMed ID: 36484305
[TBL] [Abstract] [Full Text] [Related]
3. Patient-Derived In Vitro and In Vivo Models of cancer.
Claridge SE; Cavallo JA; Hopkins BD
Adv Exp Med Biol; 2022; 1361():215-233. PubMed ID: 35230691
[TBL] [Abstract] [Full Text] [Related]
4. Design and evaluation of peptide-18-targeted nanoliposomes constructed by poly(2-oxazoline)-DOPE for doxorubicin delivery.
Devrim B; Bolat ZB; Telci D; Şahin F; Gulyuz S; Ozkose UU; Yilmaz O; Bozkır A
J Microencapsul; 2021 Aug; 38(5):285-297. PubMed ID: 33853478
[TBL] [Abstract] [Full Text] [Related]
5. Assessing the prognostic value of stemness-related genes in breast cancer patients.
Wang WJ; Wang H; Wang MS; Huang YQ; Ma YY; Qi J; Shi JP; Li W
Sci Rep; 2020 Oct; 10(1):18325. PubMed ID: 33110086
[TBL] [Abstract] [Full Text] [Related]
6. breast cancer Cell Detection and Characterization from breast Milk-Derived Cells.
Bhat-Nakshatri P; Kumar B; Simpson E; Ludwig KK; Cox ML; Gao H; Liu Y; Nakshatri H
Cancer Res; 2020 Nov; 80(21):4828-4839. PubMed ID: 32934021
[TBL] [Abstract] [Full Text] [Related]
7. A Signature That May Be Predictive of Early Versus Late Recurrence After Radiation treatment for breast cancer That May Inform the Biology of Early, Aggressive Recurrences.
Speers C; Chang SL; Pesch A; Ritter C; Olsen E; Chandler B; Moubadder L; Liu M; Cameron M; Michmerhuizen A; Wilder-Romans K; Zhao SG; Nyati S; Bartelink H; Feng FY; Pierce LJ
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):686-696. PubMed ID: 32434041
[TBL] [Abstract] [Full Text] [Related]
8. Estimating breast tissue-specific DNA methylation age using next-generation sequencing data.
Castle JR; Lin N; Liu J; Storniolo AMV; Shendre A; Hou L; Horvath S; Liu Y; Wang C; He C
Clin Epigenetics; 2020 Mar; 12(1):45. PubMed ID: 32164769
[TBL] [Abstract] [Full Text] [Related]
9. Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study.
Kawaguchi H; Masuda N; Nakayama T; Aogi K; Anan K; Ito Y; Ohtani S; Sato N; Saji S; Takano T; Tokunaga E; Nakamura S; Hasegawa Y; Hattori M; Fujisawa T; Morita S; Yamaguchi M; Yamashita H; Yamashita T; Yamamoto Y; Yotsumoto D; Toi M; Ohno S
Breast Cancer; 2020 May; 27(3):389-398. PubMed ID: 31811519
[TBL] [Abstract] [Full Text] [Related]
10. Management of placental site trophoblastic tumor: Two case reports.
De Nola R; Schönauer LM; Fiore MG; Loverro M; Carriero C; Di Naro E
Medicine (Baltimore); 2018 Nov; 97(48):e13439. PubMed ID: 30508960
[TBL] [Abstract] [Full Text] [Related]
11. Identification of transcription factor-miRNA-lncRNA feed-forward loops in breast cancer subtypes.
Jiang L; Yu X; Ma X; Liu H; Zhou S; Zhou X; Meng Q; Wang L; Jiang W
Comput Biol Chem; 2019 Feb; 78():1-7. PubMed ID: 30476706
[TBL] [Abstract] [Full Text] [Related]
12. Complementary Medicine, Refusal of Conventional cancer Therapy, and Survival Among Patients With Curable cancers.
Johnson SB; Park HS; Gross CP; Yu JB
JAMA Oncol; 2018 Oct; 4(10):1375-1381. PubMed ID: 30027204
[TBL] [Abstract] [Full Text] [Related]
13. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract] [Full Text] [Related]
14. Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ.
Maxwell AJ; Clements K; Hilton B; Dodwell DJ; Evans A; Kearins O; Pinder SE; Thomas J; Wallis MG; Thompson AM;
Eur J Surg Oncol; 2018 Apr; 44(4):429-435. PubMed ID: 29398324
[TBL] [Abstract] [Full Text] [Related]
15. Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer.
Araki K; Miyoshi Y
Breast Cancer; 2018 Jul; 25(4):392-401. PubMed ID: 29086897
[TBL] [Abstract] [Full Text] [Related]
16. Primary Pediatric breast Lesions: Comparing the Prevalence of Malignancies in the Middle East with North America; Review of 1031 Cases.
Broecker JS; Khoshnam N; Thompson L; Anis S; Kamal N; Gillespie S; Kantarovich D; Metry D; Mills MP; Drummey R; Williams B; Shehata BM
Fetal Pediatr Pathol; 2017 Apr; 36(2):139-148. PubMed ID: 28426344
[TBL] [Abstract] [Full Text] [Related]
17. Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari).
Kawaguchi H; Masuda N; Nakayama T; Aogi K; Anan K; Ito Y; Ohtani S; Sato N; Saji S; Tokunaga E; Nakamura S; Hasegawa Y; Hattori M; Fujisawa T; Morita S; Yamaguchi M; Yamashita T; Yamamoto Y; Ohno S; Toi M
Breast Cancer Res Treat; 2017 Jun; 163(3):545-554. PubMed ID: 28337663
[TBL] [Abstract] [Full Text] [Related]
18. Indolo-pyrido-isoquinolin based alkaloid inhibits growth, invasion and migration of breast cancer cells via activation of p53-miR34a axis.
Avtanski DB; Nagalingam A; Tomaszewski JE; Risbood P; Difillippantonio MJ; Saxena NK; Malhotra SV; Sharma D
Mol Oncol; 2016 Aug; 10(7):1118-32. PubMed ID: 27259808
[TBL] [Abstract] [Full Text] [Related]
19. Cytotoxic Impact of Costunolide Isolated from Costus speciosus on breast cancer via Differential Regulation of Cell Cycle-An In-vitro and In-silico Approach.
Roy A; Manikkam R
Phytother Res; 2015 Oct; 29(10):1532-9. PubMed ID: 26178525
[TBL] [Abstract] [Full Text] [Related]
20. Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of breast Diseases Societies.
Ozmen V; Boylu S; Ok E; Canturk NZ; Celik V; Kapkac M; Girgin S; Tireli M; Ihtiyar E; Demircan O; Baskan MS; Koyuncu A; Tasdelen I; Dumanli E; Ozdener F; Zaborek P
Eur J Public Health; 2015 Feb; 25(1):9-14. PubMed ID: 25096257
[TBL] [Abstract] [Full Text] [Related]
[Next]
